Literature DB >> 19002011

Successful treatment of hypereosinophilic syndrome with cyclosporine.

Chancellor E Donald1, Marc J Kahn.   

Abstract

A 63-year-old man with lymphocytic variant hypereosinophilic syndrome (HES) characterized by a T-cell receptor gene rearrangement was treated with cyclosporine with marked improvement in his symptoms and reduction in his total eosinophil count. We present this as the first report to demonstrate cyclosporine as an effective treatment of HES in an adult.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19002011     DOI: 10.1097/MAJ.0b013e318169569a

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  2 in total

1.  NIK prevents the development of hypereosinophilic syndrome-like disease in mice independent of IKKα activation.

Authors:  Hans Häcker; Liying Chi; Jerold E Rehg; Vanessa Redecke
Journal:  J Immunol       Date:  2012-04-02       Impact factor: 5.422

2.  Successful treatment of steroid resistant hypereosinophilic syndrome with low-dose CsA.

Authors:  Yun Hwa Jung; Sang Bong Han; Young Jae Park; In Sook Woo; Baik Kee Cho; Chi Wha Han
Journal:  Blood Res       Date:  2013-12-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.